All Stories

Agenus CMO touts immunotherapy advances on The Top Line

Dr. Steven O'Day of Agenus discusses the future of cancer immunotherapy on The Top Line podcast. Learn about 'cold' tumors and a potential '2.0 revolution' in immuno-oncology.

Mar 17, 2025 - 13:10
 0
Agenus CMO touts immunotherapy advances on The Top Line
Dr. Steven O'Day of Agenus discusses the future of cancer immunotherapy on The Top Line podcast. Learn about 'cold' tumors and a potential '2.0 revolution' in immuno-oncology.
Read More

Tags:

Previous Article

Think Roundtrip Flights Save You Money? One-Ways Offer More Flexibility—And Can ...

Next Article

Copenhagen Infrastructure Partners raises €12 billion in fifth renewables fund

Related Posts

After phase 3 miss, Relmada picks up midstage Tourette’s asset from Swedish biotech

After phase 3 miss, Relmada picks up midstage Tourette’...

Feb 9, 2025  0

Novo Nordisk links CagriSema to 16% weight loss, sending stock down again

Novo Nordisk links CagriSema to 16% weight loss, sendin...

Mar 10, 2025  0

Kiniksa adds to Sjögren's exodus with trial termination, axes AstraZeneca asset

Kiniksa adds to Sjögren's exodus with trial termination...

Feb 26, 2025  0